A detailed history of Wintrust Investments LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wintrust Investments LLC holds 2,207 shares of EW stock, worth $165,105. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,207
Previous 3,419 35.45%
Holding current value
$165,105
Previous $315,000 53.97%
% of portfolio
0.12%
Previous 0.03%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$59.7 - $93.78 $72,356 - $113,661
-1,212 Reduced 35.45%
2,207 $145,000
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $14,331 - $16,032
170 Added 5.23%
3,419 $315,000
Q1 2024

May 09, 2024

SELL
$72.54 - $95.56 $1.07 Million - $1.41 Million
-14,730 Reduced 81.93%
3,249 $310,000
Q4 2023

Feb 12, 2024

BUY
$61.71 - $77.76 $153,472 - $193,389
2,487 Added 16.05%
17,979 $1.37 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $257,860 - $347,560
3,722 Added 31.62%
15,492 $1.07 Million
Q2 2023

Aug 10, 2023

BUY
$81.41 - $94.33 $59,836 - $69,332
735 Added 6.66%
11,770 $1.11 Million
Q1 2023

May 09, 2023

BUY
$74.26 - $84.51 $200,502 - $228,177
2,700 Added 32.39%
11,035 $912,000
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $569,280 - $728,812
8,335 New
8,335 $622,000
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $451,097 - $668,928
-5,215 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$101.96 - $128.34 $96,862 - $121,923
-950 Reduced 15.41%
5,215 $614,000
Q4 2021

Feb 04, 2022

SELL
$106.37 - $130.68 $36,165 - $44,431
-340 Reduced 5.23%
6,165 $799,000
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $20,067 - $23,936
-195 Reduced 2.91%
6,505 $736,000
Q2 2021

Aug 10, 2021

SELL
$83.84 - $104.76 $19,702 - $24,618
-235 Reduced 3.39%
6,700 $694,000
Q1 2021

May 10, 2021

BUY
$78.68 - $90.67 $545,645 - $628,796
6,935 New
6,935 $580,000
Q4 2020

Feb 08, 2021

SELL
$71.69 - $91.23 $307,119 - $390,829
-4,284 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $22,105 - $28,767
329 Added 8.32%
4,284 $342,000
Q2 2020

Aug 07, 2020

BUY
$57.54 - $76.95 $147,014 - $196,607
2,555 Added 182.5%
3,955 $273,000
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $20,439 - $31,590
390 Added 38.61%
1,400 $264,000
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $3,585 - $4,104
-50 Reduced 4.72%
1,010 $236,000
Q3 2019

Nov 07, 2019

SELL
$61.55 - $75.43 $18,711 - $22,930
-304 Reduced 22.29%
1,060 $233,000
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $2,394 - $3,202
-50 Reduced 3.54%
1,364 $261,000
Q4 2018

Feb 13, 2019

SELL
$46.41 - $56.94 $11,416 - $14,007
-246 Reduced 14.82%
1,414 $217,000
Q3 2018

Nov 13, 2018

SELL
$45.7 - $58.03 $685 - $870
-15 Reduced 0.9%
1,660 $289,000
Q2 2018

Aug 13, 2018

SELL
$42.45 - $51.3 $24,621 - $29,754
-580 Reduced 25.72%
1,675 $244,000
Q3 2017

Nov 07, 2017

BUY
$36.29 - $38.83 $81,833 - $87,561
2,255
2,255 $246,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Wintrust Investments LLC Portfolio

Follow Wintrust Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wintrust Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wintrust Investments LLC with notifications on news.